Health
Moffitt researchers reveal why some ovarian cancer patients evolve better than others – News-Medical.Net
The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed….
The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed. These poor outcomes are partly due to the lack of effective therapies for advanced disease and recurrence. Immunotherapies hold promise for many types of cancer; however, studies have shown that patients with ovarian cancer do not have strong responses to existing drugs.
In a new article published in Nature, Moffitt Cancer Center…
-
General21 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News7 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Noosa News22 hours agoPerth Royal Show attendance slumps to 10-year low
-
General19 hours agoAn open letter to pro-Palestinian protesters